Valturna, a new combination of Diovan (valsartan) and Tekturna (aliskiren) for hypertension

December 2009

Novartis will promote Valturna, a new combination of Diovan (valsartan) and Tekturna (aliskiren) for hypertension.

Valturna will be promoted for patients who need more than one drug to control their BP...but this combo is usually not the best choice.

Both Diovan and Tekturna inhibit the renin-angiotensin system.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote